Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Achilles Therapeutics (NASDAQ:ACHL) reported its Q1 earnings results on Wednesday, May 10, 2023 at 07:00 AM.
Here's what investors need to know about the announcement.
Achilles Therapeutics missed estimated earnings by 10.0%, reporting an EPS of $-0.44 versus an estimate of $-0.4.
Revenue was down $0 from the same period last year.
Last quarter the company missed on EPS by $0.2 which was followed by a 2.8% drop in the share price the next day.
Listen to the earnings announcement yourself by clicking here.
To track all earnings releases for Achilles Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: ACHL